Amphastar Pharmaceuticals (AMPH) Change in Accured Expenses (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Change in Accured Expenses of $9.6 million for Q1 2026, down 45.45% year-over-year from $17.6 million in Q1 2025, and up 122.52% quarter-over-quarter from -$42.6 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Change in Accured Expenses (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Change in Accured Expenses history runs 14 years deep, the most recent figure standing at $9.6 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses fell 45.45% year-over-year to $9.6 million; the TTM figure through Mar 2026 stood at -$12.6 million (down 121.62% YoY), while the FY2025 annual figure was -$4.6 million, down 107.17% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $9.6 million, up from -$42.6 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $25.3 million in Q3 2025, with the low at -$42.6 million in Q4 2025.
- The 5-year median for Change in Accured Expenses is $5.5 million (2023), against an average of $4.8 million.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses surged 2803.38% in 2023, then tumbled 2119.13% in 2025.
- Amphastar Pharmaceuticals' Change in Accured Expenses stood at -$13.6 million in 2022, then surged by 75.06% to -$3.4 million in 2023, then surged by 162.34% to $2.1 million in 2024, then sank by 2119.13% to -$42.6 million in 2025, then soared by 122.52% to $9.6 million in 2026.
- Business Quant data shows AMPH's Change in Accured Expenses at $9.6 million in Q1 2026, -$42.6 million in Q4 2025, and $25.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 943.15 Mn | 653.02 Mn | 93.47 Mn | 1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.96 Mn |
| Jun 30, 2026 | 1.96 Mn |
| Mar 31, 2026 | 9.60 Mn |
| Mar 31, 2026 | 9.60 Mn |
| Dec 31, 2025 | -42.64 Mn |
| Dec 31, 2025 | -42.64 Mn |
| Sep 30, 2025 | 25.34 Mn |
| Sep 30, 2025 | 25.34 Mn |
| Jun 30, 2025 | -4.86 Mn |
| Jun 30, 2025 | -4.86 Mn |
| Mar 31, 2025 | 17.61 Mn |
| Mar 31, 2025 | 17.61 Mn |
| Dec 31, 2024 | 2.11 Mn |
| Dec 31, 2024 | 2.11 Mn |
| Sep 30, 2024 | 24.65 Mn |
| Sep 30, 2024 | 24.65 Mn |
| Jun 30, 2024 | 13.73 Mn |
| Jun 30, 2024 | 13.73 Mn |
| Mar 31, 2024 | 23.08 Mn |
| Mar 31, 2024 | 23.08 Mn |